Under the National AIDS Control Programme (NACP V), the 95-95-95 strategy by 2025 means:
- A 95% of PLHIV linked to care, 95% retained in care, 95% with CD4 count >200
- B 95% reduction in new infections, 95% reduction in AIDS-related deaths, 95% coverage of PMTCT
- C 95% of HIV+ diagnosed, 95% of those diagnosed on ART, 95% of those on ART virally suppressed ✓
- D 95% of high-risk groups tested, 95% of positives started on TLD, 95% adherent at 1 year
Explanation
The UNAIDS 95-95-95 target (successor to 90-90-90) states: 95% of all people living with HIV know their status, 95% of those diagnosed are on sustained antiretroviral therapy (ART), and 95% of those on ART achieve viral suppression. This cascade approach drives epidemic control. Under NACP V, India aims to achieve these targets by 2025 using TLD (Tenofovir-Lamivudine-Dolutegravir) as the preferred first-line regimen for adults. The goals focus on the treatment cascade, not just infection reduction or CD4 thresholds.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.